转自：每日经济新闻 来源：每日经济新闻 原标题：西南证券给予承德露露"买入"评级，2025年三季报点评：费用投放持续，期待新品成效 据每日经济新闻消息，西南证券10月30日发布研报称，给予承德露露（000848.SZ，最新价：9.04 元）"买入"评级。评级理由主要包括：1）杏仁露主业稳健，新品布局打开成长空间；2）成本红利显著 释放，盈利能力稳步提升；3）股权激励到位，新品积极布局。风险提示：市场竞争加剧、原材料供应 及价格波动、新品推广不达预期等风险。 ...

Market Overview - The beverage and dairy sector increased by 0.4% compared to the previous trading day, with Junyao Health leading the gains [1] - The Shanghai Composite Index closed at 3954.79, down 0.81%, while the Shenzhen Component Index closed at 13378.21, down 1.14% [1] Stock Performance - Junyao Health (605388) closed at 7.37, up 3.37% with a trading volume of 120,100 shares and a turnover of 87.84 million yuan [1] - Weiweijia (600300) closed at 3.58, up 3.17% with a trading volume of 1,225,600 shares and a turnover of 436 million yuan [1] - New Dairy (002946) closed at 17.42, up 2.41% with a trading volume of 88,900 shares and a turnover of 15.3 million yuan [1] - Other notable stocks include Panda Dairy (300898) up 1.77% and Miaokelan Duo (600882) up 1.95% [1] Capital Flow - The beverage and dairy sector saw a net inflow of 70.53 million yuan from institutional investors, while retail investors contributed a net inflow of 150 million yuan [2] - However, there was a net outflow of 221 million yuan from speculative funds [2] Individual Stock Capital Flow - Chengde Lulu (000848) had a net inflow of 49.92 million yuan from institutional investors, but a net outflow of 64.64 million yuan from speculative funds [3] - Dongpeng Beverage (605499) experienced a net inflow of 33.18 million yuan from institutional investors, with a slight outflow from speculative funds [3] - Weiweijia (600300) had a net inflow of 19.50 million yuan from institutional investors, while retail investors saw a net outflow of 20.42 million yuan [3]

Market Overview - The beverage and dairy sector experienced a decline of 0.54% on the trading day, with Junyao Health leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the beverage and dairy sector included: - Weiweijia (600300) with a closing price of 3.47, up 2.97% [1] - New Dairy (002946) at 17.01, up 2.47% [1] - Yili (600887) at 27.36, up 0.66% with a transaction volume of 621,200 shares and a transaction value of 1.702 billion [1] - Major decliners included: - Junyao Health (605388) at 7.13, down 3.52% [2] - Happy Home (300997) at 16.62, down 3.26% [2] - Beiyinmei (002570) at 6.28, down 2.64% with a transaction value of 305 million [2] Capital Flow - The beverage and dairy sector saw a net inflow of 193 million from institutional investors, while retail investors experienced a net outflow of 39.39 million [2] - The capital flow for key stocks showed: - Yili (600887) had a net inflow of 285 million from institutional investors, but a net outflow of 172 million from retail investors [3] - Chengde Lululemon (000848) had a net inflow of 42.62 million from institutional investors, with a net outflow of 5.37 million from retail investors [3] - Miao Ke Lan Duo (600882) had a net inflow of 20.36 million from institutional investors, but a significant net outflow of 29.61 million from retail investors [3]

Core Viewpoint - Chengde Lululemon's stock price has shown a positive trend with a year-to-date increase of 4.83%, indicating potential investor interest and market confidence in the company's performance [1][2]. Financial Performance - For the period from January to September 2025, Chengde Lululemon reported a revenue of 1.956 billion yuan, a year-on-year decrease of 9.42%, and a net profit attributable to shareholders of 384 million yuan, down 8.47% compared to the previous year [2]. - The company has distributed a total of 4.248 billion yuan in dividends since its A-share listing, with 1.044 billion yuan distributed over the last three years [3]. Shareholder Information - As of October 20, 2025, the number of shareholders for Chengde Lululemon was 56,000, a decrease of 1.59% from the previous period, while the average circulating shares per person increased by 1.62% to 18,623 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited as the second-largest shareholder with 20.5825 million shares, an increase of 1.7903 million shares from the previous period [3]. Market Activity - On October 30, the stock price of Chengde Lululemon rose by 2.02%, reaching 9.09 yuan per share, with a trading volume of 194 million yuan and a turnover rate of 2.07% [1]. - The net inflow of main funds was 36.3781 million yuan, with significant buying activity from large orders amounting to 69.6668 million yuan, indicating strong market interest [1].

证券日报网讯承德露露（000848）10月28日在互动平台回答投资者提问时表示，公司按照回购计划及进 度提取回购专项贷款，贷款使用遵循相关法律法规和规范性文件等的规定。 ...

Core Insights - Chengde Lululemon reported that as of October 20, 2025, the total number of shareholders is 55,981 [2] Summary by Category - **Company Information** - Chengde Lululemon has a total of 55,981 shareholders as of the specified date [2] - **Investor Communication** - The company addressed investor inquiries on an interactive platform regarding shareholder numbers [2]

Core Viewpoint - Chengde Lulux's stock price has shown a slight increase recently, with a year-to-date rise of 3.79%, indicating a stable performance in the beverage sector despite a decline in revenue and profit [1][2]. Financial Performance - For the period from January to September 2025, Chengde Lulux reported a revenue of 1.956 billion yuan, a year-on-year decrease of 9.42%, and a net profit attributable to shareholders of 384 million yuan, down 8.47% compared to the previous year [2]. - The company has cumulatively distributed 4.248 billion yuan in dividends since its A-share listing, with 1.044 billion yuan distributed over the last three years [3]. Stock Market Activity - As of October 27, the stock price of Chengde Lulux was 9.00 yuan per share, with a market capitalization of 9.473 billion yuan. The stock experienced a trading volume of 90.024 million yuan and a turnover rate of 0.97% [1]. - The net inflow of main funds was 8.5199 million yuan, with significant buying and selling activities observed [1]. Shareholder Structure - As of October 10, the number of shareholders for Chengde Lulux was 56,900, a slight decrease of 0.17% from the previous period, while the average circulating shares per person increased by 0.17% to 18,326 shares [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 20.5825 million shares, an increase of 1.7903 million shares from the previous period [3].

Core Insights - The article discusses the recent adjustments in QFII (Qualified Foreign Institutional Investor) holdings in A-shares as companies disclose their Q3 reports, highlighting a clear trend in foreign investment strategies [1][2]. Group 1: Sovereign Wealth Fund Adjustments - Sovereign wealth funds like the Abu Dhabi Investment Authority (ADIA) and the Monetary Authority of Macao have shown distinct trading behaviors, with ADIA significantly increasing its holdings in cyclical resource stocks, particularly Baofeng Energy, which now has a market value exceeding 790 million yuan [3][4]. - In contrast, the Monetary Authority of Macao has adopted a more defensive and stable investment strategy, focusing on resource, environmental, and manufacturing sectors, with a total market value of 1.14 billion yuan across six stocks [3][4]. - The Hong Kong Monetary Authority has reduced its holdings in Chengde Lolo, now holding 9.3 million shares, indicating a cautious approach compared to ADIA's aggressive positioning [4]. Group 2: Traditional Foreign Banks' Strategies - Major foreign banks like Morgan Stanley, UBS, and Goldman Sachs have shown a trend towards concentrated investments in high-certainty sectors, with Morgan Stanley holding 42 A-shares valued at 2.874 billion yuan, focusing on electric power equipment and digital infrastructure [5][6]. - Morgan Chase has the largest coverage with 71 A-shares, significantly increasing its stake in China West Electric from 56.82 million shares to 130 million shares, reflecting a strategic shift towards high-potential stocks [5]. - UBS has diversified its holdings across 55 A-shares, emphasizing mid-to-small-cap growth stocks, while Goldman Sachs has concentrated on resource and chemical stocks, indicating varied investment philosophies among these institutions [5][6]. Group 3: Common Holdings Among Foreign Institutions - Several stocks have emerged as "foreign consensus stocks," held by three or more foreign institutions, indicating strong compatibility in valuation, fundamentals, and policy direction [7][8]. - Notable examples include Chengfei Integration, which is held by multiple institutions with a total market value exceeding 132 million yuan, and Innovation Medical, favored by four foreign entities [7][8]. - Other stocks like Lianhuan Pharmaceutical and Xingwang Yuda have also gained traction among foreign investors, showcasing a trend towards core assets in advanced manufacturing, healthcare, TMT, and military materials sectors [8].

Core Viewpoint - Chengde Lulule's financial performance in the first three quarters of 2025 shows a decline in both revenue and net profit, reflecting ongoing challenges in consumer demand and seasonal sales fluctuations [1] Financial Performance - For the first three quarters of 2025, the company achieved operating revenue of approximately 1.956 billion yuan, a year-on-year decrease of 9.42% [1] - The net profit attributable to shareholders was about 384 million yuan, down 8.47% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately 382 million yuan, a decline of 8.55% year-on-year [1] Sales and Market Conditions - The company experiences significant seasonal sales variations, with the first quarter of 2025 facing pressure due to an early Spring Festival and a continuation of weak overall consumer sentiment [1] - Revenue in the first half of 2025 decreased by 15.30% year-on-year [1] - Despite underperformance in the first half, the third quarter showed better-than-expected revenue performance as the company accelerated its efforts to meet targets for the second year of its equity incentive plan [1] Product Development - The main product contributing to revenue remains almond milk, while new products are still in the cultivation phase, with some contribution in the third quarter but not yet significant [1] Project Development - The construction project for "annual production of 150,000 tons of Lulule series beverages" is progressing, with 90% of the foundation work completed, 85% of the main structure finished, and 10% of the secondary structure completed as of September 30, 2025 [1]

Group 1: OSL Group - OSL Group is currently the only publicly listed licensed virtual asset exchange in Asia, benefiting from a rare licensing barrier and diversified product expansion, which provides a first-mover advantage [1][3] - The company is expected to achieve profitability for the first time in 2024 since its strategic shift to the digital asset industry in 2018, with net profits projected to be -0.66/-0.12/0.20 million HKD for 2025-2027 [2][24] - OSL has obtained dual licenses from the Hong Kong Securities and Futures Commission (SFC) and Anti-Money Laundering Ordinance (AMLO), ensuring compliance and regulatory framework for its operations [3][25] - The company is accelerating global expansion through acquisitions in Japan and Europe, which is expected to drive significant revenue growth [3][25] - A strategic investment of up to 30 million USD in the PayFi ecosystem is planned to enhance payment services, which will be a key focus area for the company in the coming years [4][26] Group 2: Chengde Lululemon - Chengde Lululemon reported a significant revenue recovery in Q3, with a year-on-year growth of 8.91%, although the increase in sales expenses offset the gross margin expansion [5][6] - The company is focusing on the launch of new products, particularly the Lululemon plant-based health water series, which is expected to enhance brand competitiveness and capture market demand [7] - The market for traditional health water is projected to grow significantly, with an expected market size of 30 billion RMB in 2024, indicating a favorable environment for the company's new product line [7] Group 3: GCL Technology - GCL Technology's photovoltaic materials business turned profitable in Q3 2025, with an estimated profit of approximately 9.6 billion RMB, marking a significant recovery [8][34] - The company is expected to achieve net profits of -13.81/13.17/20.55 billion RMB for 2025-2027, reflecting a positive outlook for future profitability [8][34] - The company is benefiting from a reduction in competition and a focus on core business areas, which is expected to enhance its operational efficiency [8][34]